In addition, other studies have revealed that blocking the secretion or action of soluble S100A8/A9 complex might be a promising therapeutic strategy in surviving sufferers, who had lessen amounts of S100A8/A9, when compared with non-survivors. The blocking has the probable to prevent liver harm and bacterial dissemination in the early stages of se